FDA investigates the reports of infections associated with reprocessed urological endoscope

The FDA puts its best foot forward to ensure safety in regard to reprocessed medical devices. The FDA is actively engaged to help understand the risk and the causes associated with endoscopic procedures.

Endoscopic Superbugs infections 

Doctors use an endoscope to look inside the patient’s body to screen for disease and in some cases treat existing conditions. Endoscopic devices consist of light video cameras attached to long thin plastic tubes. Certain endoscopes come under scrutiny for potentially spreading the carbapenem-resistant Enterobacteria - a potentially deadly antibiotic resistant infection even when proper disinfection procedures are followed. 

According to FDA, duodenoscopes, a type of endoscope used for endoscopic retrograde cholangiopancreatography (ERCP) procedures to examine the GIT system especially the pancreatic and bile ducts are designed in a way that may prevent the full cleaning and disinfection. If you have come across anyone who has unexplained illness after an endoscopic procedure, there are higher chances of infection. 

Sterilizing endoscopic devices are important 

Sterilizing the duodenoscopes between the uses requires hospital personnel to pay detailed attention to it. It is important for the safety of the patients to sterilize and disinfect the endoscopic medical devices and instruments regularly after each use. A multi-step process and detailed thorough cleaning and disinfection is a must to eliminate the risk and reduce the risk of transmitting serious infections. These infections can cause life-threatening conditions between the uses. The Center for Disease Control and Prevention (CDC) has reported the potential link between the multidrug-resistant bacterial infections in patients who have undergone endoscopic procedures with the reprocessed medical devices or instruments. 

FDA announcements regarding the Reprocessed endoscopic devices

The FDA announced that it is investigating numerous medical devices causing patient infection and other possible contamination issues due to the reuse. The reprocessed urological endoscopic devices like cystoscope, ureteroscope, and cystourethroscopy devices which are needed to view the urinary tract and system have higher chances of spreading infection among the patients exposed to endoscopy.

Reprocessing of the medical devices involves both cleaning, disinfection, and sterilization of the devices and instruments before reuse. Medical devices are supposed to improve your care and not put you at risk of potentially fatal infection. If anyone has contracted the infection due to the endoscopic procedure, it is important to bring it to light. Proper guidance must be given to the hospital personnel to take further action to prevent these types of infection which can spread through the contamination of medical devices. 

FDA action incase of reprocessing of medical devices 

From Jan 1 2017 to Feb 20, 2021, the FDA received over 450 Medical Devices Reprocessed describing post-procedure patient infections or other possible contamination issues associated with reprocessing these devices. Many medical device companies were cited in the FDA's reports. The FDA is continuing to investigate these reports, but the FDA has not concluded any specific manufacturer or brand of devices to be associated with a higher risk of contamination. 

The letter to health care providers, hospitals, and medical professionals on April 1, 2021, provides recommendations of reprocessing and using the devices as per the instructions laid by the FDA. It is important to discuss and know the potential risk and benefits associated with the procedures involving reprocessed urological endoscopes with patients. 

Tags : #FDA #medicaldevices #endoscope #bacterialinfection #medicircle #myhealth

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Karan Johar and Guneet Monga Kapoor’s 'Gyaarah Gyaarah' trailer breaks time barriers on ZEE5July 26, 2024
If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Investing in India’s Path to a Healthier and Brighter FutureJuly 26, 2024
Your Medication Could Be Useless This Summer: How Heat Waves Affect Drug SafetyJuly 26, 2024
Innovative Approach to Adolescent Weight Loss: Combining Meal-Replacement Therapy with Financial IncentivesJuly 26, 2024
Promoting School Cardiopulmonary Resuscitation (CPR) Program in India: A Step Towards Saving LivesJuly 26, 2024
Education Budget 2024: A Step Towards Better Learning : Gargi Limaye July 25, 2024
AI assistant shows great promise in cataract care pathwayJuly 25, 2024
Publishing Powerhouse Devangini : A Force of Resilience and Empowerment in LiteratureJuly 25, 2024
Alarm rings in Asia Pacific for not making U-equals-U and HIV prevention accessible to allJuly 25, 2024
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular DiseasesJuly 24, 2024
Nurturing Souls revolutionises 1000 Child-Parent Relationships for Better Career Choices & improved Mental HealthJuly 24, 2024
How to Improve Sleep Quality in Adolescents: Insights from a New StudyJuly 24, 2024
Tragic Nipah Virus Death of 14-Year-Old in Kerala: What You Need to KnowJuly 24, 2024
India Inaugurates First Overseas Jan Aushadi Kendra in MauritiusJuly 24, 2024
Budget Reaction Quote - Ms. Deepshikha Sharma, CEO, Sharp Sight Eye HospitalsJuly 23, 2024
Quote to be attributed to Mr. Jatinder Paul Singh, CEO & Co - Founder of Viacation Tourism:July 23, 2024
Budget Reaction by Anjan Bose, Founding Secretary General, NATHEALTH July 23, 2024
Mr. Niranjan Kirloskar, Managing Director, Fleetguard Filters Private Limited- BUDGET REACTIONJuly 23, 2024